Here are three things to know:
1. The privately-held company recently received FDA 510(k) clearance for its Voyant System, a sterile single-use, disposable retractor device with integrated visualization technology for MIS.
2. In 2017, Viseon Spine received $5 million in a series-A financing round.
3. Jeffrey Valko serves as the company’s president and CEO. He has more than 25 years of medical device industry experience.
More articles on devices:
Medacta appoints general manager of U.S. spine division: 3 insights
Medtronic, DePuy Synthes & more: 11 device company launches, releases
5 things to know about NuVasive’s new CEO J. Christopher Barry
